Rachel K. King - 30 Sep 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
30 Sep 2023
Net transactions value
+$10,000
Form type
4
Filing time
03 Oct 2023, 16:05:17 UTC
Previous filing
13 Jun 2023
Next filing
02 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common stock Award $10,000 +6,667 +1.3% $1.50 507,622 30 Sep 2023 Direct F1
holding GLYC Common stock 7,500 30 Sep 2023 By RBK LLC F2
holding GLYC Common stock 92,401 30 Sep 2023 By trusts F3
holding GLYC Common stock 45,741 30 Sep 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board retainer fees of $10,000.
F2 The reporting person is co-manager of this entity. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F3 These shares are held by family trusts, for which Ms. King serves as trustee, as follows: 1,741 shares are held by The Connor A. King 1988 Trust, 1,741 shares are held by The Langley C. King 1990 Trust, 8,796 shares are held by the 1995 Connor A. King Trust, 8,796 shares are held by the 1995 Langley C. King Trust, 23,301 shares are held by The Connor King 2013 GRAT, 23,301 shares are held by The Langley C. King 2013 GRAT and 24,725 shares are held by The Rachel K. King 2016 GRAT.